MARSHALL BROWNING HOSPITAL — History
CCN 141331 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$31M
Latest Revenue (FY2022)
+14.0%
Revenue CAGR (3yr)
-7.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $27M | $31M | +14.4% | +14.0% |
| Operating Expenses | $25M | $29M | $33M | +13.6% | +14.0% |
| Operating Margin | -7.4% | -8.1% | -7.4% | +8.7% | +0.0% |
| Net Income | $-2M | $-2M | $-2M | -4.4% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,706 | 3,256 | 2,738 | -15.9% | +26.7% |
| Medicare Day % | 72% | 66% | 69% | +4.6% | -2.0% |
| Medicaid Day % | 0% | 1% | 0% | -89.7% | -54.4% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +30.0% ($24M → $31M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.0%
This Hospital
+7.6%
State Avg
Latest Margin
-7.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $34M | -7.3% |
| FY2024 (proj) | $38M | -7.3% |
| FY2025 (proj) | $41M | -7.3% |